Literature DB >> 18453862

Does tenofovir increase efavirenz hepatotoxicity?

Emanuela Lattuada, Massimiliano Lanzafame, Giada Carolo, Martina Gottardi, Ercole Concia, Sandro Vento.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18453862     DOI： 10.1097/QAD.0b013e3282fc27c4

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

Review 1.  EFV/FTC/TDF-associated hepatotoxicity: a case report and review.

Authors:  Ignacio A Echenique; Josiah D Rich
Journal:  AIDS Patient Care STDS       Date:  2013-08-12       Impact factor: 5.078

2.  Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.

Authors:  Helen Kovari; Caroline A Sabin; Bruno Ledergerber; Lene Ryom; Peter Reiss; Matthew Law; Christian Pradier; Francois Dabis; Antonella d'Arminio Monforte; Colette Smith; Stephane de Wit; Ole Kirk; Jens D Lundgren; Rainer Weber
Journal:  Open Forum Infect Dis       Date:  2016-01-21       Impact factor: 3.835

3.  Evaluation of Adverse Drug Reaction Profile of Drugs Used as First-Line Antiretroviral Therapy.

Authors:  Mukta N Chowta; Priyanka Kamath; John T Ramapuram; K Ashok Shenoy; Sanjay Hadigal
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-08-02

4.  Spatial Distribution Profiles of Emtricitabine, Tenofovir, Efavirenz, and Rilpivirine in Murine Tissues Following In Vivo Dosing Correlate with Their Safety Profiles in Humans.

Authors:  Herana Kamal Seneviratne; Allyson N Hamlin; Carley J S Heck; Namandjé N Bumpus
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.